Close

Dr Ajay Aggarwal

MSc MRCP FRCR PhD

Associate Professor
NIHR Advanced Fellow

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I am a Consultant Clinical Oncologist at Guy's St Thomas' NHS Trust specialising in the delivery of radiation and systemic therapies for cancer. In 2020 I received a National Institute for Health Research (NIHR) Advanced Fellowship to undertake a four-year programme of research to inform different options for the re-design of NHS cancer treatment services to optimise equity, access and outcomes using both qualitative and quantitative "big data" methods (epidemiology, GIS and econometrics). 

I graduated from Guy’s, Kings’ & St Thomas’ Medical school having attained a BSc in Management at Imperial College London. I have an MSc in the Science of Cancer from The Institute of Cancer Research and an MSc in Health, Population and Society from The London School of Economics. I completed my PhD in Health Services Research at LSHTM as part of a NIHR Doctoral Research Fellowship. In addition to my role at LSHTM I have honorary senior lecturer positions at the Institute of Cancer Policy (King's College London) where I co-director of the global oncology group and the MRC Clincial Trials Unit (University College London).

I am the current editor of the Journal of Cancer Policy. 

Affiliations

Faculty of Public Health and Policy
Department of Health Services Research and Policy

Teaching

I teach on the Public Health MSc at LSHTM. I am a faculty member of CREDO (International Collaboration for Research Methods Development in Oncology), which is an annual one-week research protocol development workshop involving senior oncology trainees from within and outside of India.

I am a faculty member of the Institute of Cancer Research MSc in Oncology course. I teach on two modules "Global Oncology" and "Cancer Economics". I am also a member of Faculty for the Leadership in Oncology Course organized by the European Society of Oncology.

Research

My academic career to date brings together my training in clinical oncology (radiation and medical oncology) with national and global health services research, with a particular focus on evidence-based policy implementation and impact. I have a wide skill set in research methodologies including epidemiology, demography, geographic information systems, econometrics, and qualitative methods. 

I have contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine, which has directly influenced both WHO Cancer Drug Pricing and Benefits Taskforces, and the European Medicines Agency. In my role as the Oncology Coordinator for the UK National Prostate Cancer Audit, I led the development and delivery of the first ever national hospital outcome reporting programme for radiotherapy. As chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology), I am co-leading the value-based health care initiative.

I have experience and expertise in global health research. I have previously worked at the World Health Organisation in Geneva in the TB disease domain, and have ongoing global health projects aimed at building cancer control capacity and research capability in low and middle income countries. I am the Chief Investigator of the NIH funded ARCHERY study, the first prospective international multicentre trial across India, South Africa, Jordan and Malaysia evaluating the role of AI in radiotherapy.

Research Area
Health policy
Health services research
Health systems
Electronic health records
Global Health
Discipline
Economics
Epidemiology
GIS/Spatial analysis
Medicine
Policy analysis
Social Sciences
Disease and Health Conditions
Cancer
Country
Botswana
Ghana
India
Jordan
Malaysia
Tanzania
United States of America
South Africa
Zambia
Region
European Union
Middle East & North Africa (all income levels)
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery.
Aggarwal A; Han L; Boyle J; Lewis D; Kuyruba A; Braun M; Walker K; Fearnhead N; Sullivan R; van der Meulen J
2022
JAMA surgery
Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation.
Boyle JM; van der Meulen J; Kuryba A; Cowling TE; Booth C; Fearnhead NS; Braun MS; Walker K; Aggarwal A
2022
European Journal of Cancer
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
Fankhauser CD; Parry MG; Ali A; Cowling TE; Nossiter J; Sujenthiran A; Berry B; Morris M; Aggarwal A; Payne H
2022
European journal of cancer (Oxford, England : 1990)
Impact of patient choice and hospital competition on patient outcomes after rectal cancer surgery: A national population-based study.
Han L; Boyle JM; Walker K; Kuryba A; Braun MS; Fearnhead N; Jayne D; Sullivan R; van der Meulen J; Aggarwal A
2022
Cancer
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lawler M; Davies L; Oberst S; Oliver K; Eggermont A; Schmutz A; La Vecchia C; Allemani C; Lievens Y; Naredi P
2022
The Lancet. Oncology
Cancer research across Africa: a comparative bibliometric analysis.
Mutebi M; Lewison G; Aggarwal A; Alatise OI; Booth C; Cira M; Grover S; Ginsburg O; Gralow J; Gueye S
2022
BMJ Global Health
Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict.
Van Hemelrijck M; Fox L; Beyer K; Fedaraviciute E; George G; Hadi H; Haire A; Handford J; Mera A; Monroy-Iglesias MJ
2022
Journal of cancer policy
See more Publications